Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3–4 NSCLC patients

BACKGROUND: Precision medicine has increased the accuracy of cancer diagnosis and treatment, especially in the era of cancer immunotherapy. Despite recent advances in cancer immunotherapy, the overall survival rate of advanced NSCLC patients remains low. A better classification in advanced NSCLC is...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chang, Tian, Chen, Zeng, Yulan, Liang, Jinyan, Yang, Qifan, Gu, Feifei, Hu, Yue, Liu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862473/
https://www.ncbi.nlm.nih.gov/pubmed/35193578
http://dx.doi.org/10.1186/s12920-022-01184-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862473/
https://www.ncbi.nlm.nih.gov/pubmed/35193578
http://dx.doi.org/10.1186/s12920-022-01184-1

Ejemplares similares